People / Staff

Nerea Vega García

Search publications

Publications

  • Bueno C, Torres-Ruíz R, Velasco-Hernandez T, Molina O, Petazzi P, Martinez-Moreno A, Rodríguez-Cortez VC, Vinyoles M, Cantilena S, Williams O, Vega-García N, Rodriguez-Perales S, Segovia JC, Quintana-Bustamante O, Roy A, Meyer C, Marschalek R, Smith A, Milne TA, Fraga MF, Tejedor JRR and Menendez P.

    A human genome editing-based MLL::AF4 ALL model recapitulates key cellular and molecular leukemogenic features

    Blood . 142(20): 1752-1756. Number of citations: 2

    [doi:10.1182/blood.2023020858]

  • Velasco P, Bautista F, Rubio A, Aguilar Y, Rives-Solà S, Dapena JL, Pérez A, Ramirez M, Saiz-Ladera C, Izquierdo E, Escudero A, Camós-Guijosa M, Vega-García N, Ortega M, Hidalgo-Gómez G, Palacio C, Menéndez P, Bueno C, Montero J, Romecín PA, Zazo S, Alvarez F, Parras J, Ortega-Sabater C, Chulián S, Rosa M, Cirillo D, García E, García J, Manzano-Muñoz A, Minguela A and Fuster JL.

    The relapsed acute lymphoblastic leukemia network (ReALLNet): a multidisciplinary project from the spanish society of pediatric hematology and oncology (SEHOP)

    Frontiers in pediatrics . 11: 1269560-1269560.

    [doi:10.3389/fped.2023.1269560]

  • Esperanza-Cebollada E, Gomez-Gonzalez S, Pérez-Jaume S, Vega-García N, Vicente-Garces C, Richarte M, Rives-Solà S, Català-Temprano A, Torrebadell-Burriel M and Camós-Guijosa M.

    A miRNA signature related to stemness identifies high-risk patients in paediatric acute myeloid leukaemia

    BRITISH JOURNAL OF HAEMATOLOGY . 202(1): 96-110. Number of citations: 5

    [doi:10.1111/bjh.18746]

  • Vicente-Garces C, Maynou-Fernández J, Fernandez-Isern G, Esperanza-Cebollada E, Torrebadell-Burriel M, Català-Temprano A, Rives-Solà S, Camós-Guijosa M and Vega-García N.

    Fusion InPipe, an integrative pipeline for gene fusion detection from RNA-seq data in acute pediatric leukemia

    Frontiers in Molecular Biosciences . 10: 1141310-1141310. Number of citations: 2

    [doi:10.3389/fmolb.2023.1141310]

  • García-Hernández V, Arambilet D, Guillén Y, Lobo-Jarne T, Maqueda M, Gekas C, González J, Iglesias A, Vega-García N, Sentís I, Trincado JL, Márquez-López I, Heyn H, Camós-Guijosa M, Espinosa L and Bigas A.

    ß-Catenin activity induces an RNA biosynthesis program promoting therapy resistance in T-cell acute lymphoblastic leukemia

    EMBO Molecular Medicine . 15(2): . Number of citations: 2

    [doi:10.15252/emmm.202216554]

  • Bueno C, Barrena S, Bataller A, Ortiz-Maldonado V, Elliott N, O'Byrne S, Wang G, Rovira M, Gutierrez-Agüera F, Trincado JL, Gonzalez M, Morgades M, Sorigué M, Barcena P, Zanetti SR, Torrebadell-Burriel M, Vega-García N, Rives-Solà S, Mallo M, Sole F, Mead AJ, Roberts I, Thongjuea S, Psaila B, Juan-Otero M, Delgado J, Urbano-Ispizua Á, Ribera JM, Orfao A, Roy A and Menéndez P.

    CD34+CD19-CD22+ B-cell progenitors may underlie phenotypic escape in patients treated with CD19-directed therapies

    Blood . 140(1): 38-44. Number of citations: 20

    [doi:10.1182/blood.2021014840]

  • Vicente-Garces C, Esperanza-Cebollada E, Montesdeoca S, Torrebadell-Burriel M, Rives-Solà S, Dapena JL, Català-Temprano A, Conde N, Camós-Guijosa M and Vega-García N.

    Technical Validation and Clinical Utility of an NGS Targeted Panel to Improve Molecular Characterization of Pediatric Acute Leukemia

    Frontiers in Molecular Biosciences . 9: 854098-854098. Number of citations: 4

    [doi:10.3389/fmolb.2022.854098]

  • Vega-García N, Pérez-Jaume S, Esperanza-Cebollada E, Vicente-Garces C, Torrebadell-Burriel M, Jiménez-Velasco A, Ortega M, Llop M, Abad L, Vagace JM, Minguela A, Pratcorona M, Sánchez-Garcia J, García-Calderon CB, Gómez-Casares MT, Martín-Clavero E, Escudero A, Riñón M, Muñoz L, Velasco MR, García-Morín M, Català-Temprano A, Pascual A, Velasco P, Fernandez JM, Lassaletta A, Fuster JL, Badell I, Molinos-Quintana A, Molinés A, Guerra-Garcia P, Pérez-Martínez A, García-Abós M, Robles R, Pisa S, Adán R, Díaz de Heredia C, Dapena JL, Rives-Solà S, Ramirez M and Camós-Guijosa M.

    Measurable Residual Disease Assessed by Flow-Cytometry Is a Stable Prognostic Factor for Pediatric T-Cell Acute Lymphoblastic Leukemia in Consecutive SEHOP Protocols Whereas the Impact of Oncogenetics Depends on Treatment.

    Frontiers in pediatrics . 8: 614521-614521. Number of citations: 5

    [doi:10.3389/fped.2020.614521]

  • Vega-García N, Benito R, Esperanza-Cebollada E, Llop M, Robledo C, Vicente-Garces C, Alonso J, Barragán E, Fernandez-Isern G, Hernández-Sánchez JM, Martín-Izquierdo M, Maynou-Fernández J, Minguela A, Montaño A, Ortega M, Torrebadell-Burriel M, Cervera J, Sánchez J, Jiménez-Velasco A, Riesco S, Hernández-Rivas JM, Lassaletta Á, Fernández JM, Rives-Solà S, Dapena JL, Ramírez M and Camós-Guijosa M.

    Helpful Criteria When Implementing NGS Panels in Childhood Lymphoblastic Leukemia

    Journal of Personalized Medicine . 10(4): 244. Number of citations: 1

    [doi:10.3390/jpm10040244]

  • Montano, A, Matorra-Miguel, M, Forero-Castro, M, Lumbreras, E, Santos, S, Miguel, C, Fuster, JL, De las Heras, N, Garcia-de Coca, A, Sierra, M, Davila, J, De la Fuente, I, Olivier, C, Olazabal, J, Martinez, J, Vega-García N, Camós-Guijosa M, Gonzalez, T, Hernandez-Rivas, JM and Benito, R.

    APPLICATION OF A NGS DIAGNOSTIC PANEL TO IMPROVE AND REFINE THE STRATIFICATION OF PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA B

    HAEMATOLOGICA . 105: 26-26.